Piedmont Pharmaceuticals, LLC

Over the past couple of years, real-world data (RWD) and real-world evidence (RWE) have emerged as key buzzwords along with big data, and we are set to hear even more of them, according to Richard Bar

Activity in the drug delivery sector has been geared towards alliances in 2009, says Phil Greenfield. The drug delivery sector was worth an estimated $50 billion in 2008 and is now a major sector of

Investments in private pharmaceutical and biotech companies slumped by 24% in April, with the market being once again dominated by US companies, a Scrip analysis has found. A total of 12 companies r

PPD will expand into the dermatology market and move away from preclinical oncology research in a realignment towards its core operations. The contract research organisation has acquired Magen BioScie